Ironwood Pharmaceuticals, Inc.
IRWDDrug Manufacturers - Specialty & Generic
$3.62+0.28%As of Oct 29vs prior close
- Market cap
- $598.2M
- P/E (TTM)
- 4.5×
- P/E (FY1)
- 3.0×
- From 52W high
- −32.84%
- EPS (LTM)
- $0.77
- Revenue (LTM)
- $389.3M
- Net margin
- 33.36%
- Dividend yield
- 0.00%
Nomior Score
67
Emerging BreakoutSpeculativeTop 13% of the scored universe
Growth51
Quality64
Value71
Momentum78
Resilience40
Growth
+0.87%revenue a year over 9 fiscal years
YE16 $274MLTM $389.3M
Connections
Revenue to profitQ2 YE26
45% of revenue became net profit, up 18 pts on a year.
Who owns it
2funds